Further, levels of IL‐17 were positively correlated to hypertension and dyslipidemia, indicating a prevalent inflammatory state in the Indian population of T2DM with and without complications (Journal of Diabetes Mellitus>Vol.9 No. 4, November 2019). Here, IL17A is linked to metabolic syndrome.